First Crystal Structure of an Aspartame Cocrystal. [PDF]
Cryst Growth DesFereidouni N, Aljohani M, Erxleben A.
europepmc +1 more source
Formulation Strategies to Enhance the Solubility of Poorly Water-Soluble Drugs and Phytochemicals: Current Advances and Challenges. [PDF]
PharmaceuticsJacob S, Shah H, Nair AB.
europepmc +1 more source
Developing Multi-Component Solid Formulation Strategies for PROTAC Dissolution Enhancement. [PDF]
Mol PharmScreen MA +7 more
europepmc +1 more source
Impact of the Coformer Carbon-Chain Length on the Properties of Haloperidol Pharmaceutical Salts. [PDF]
Cryst Growth DesAcebedo-Martínez FJ +5 more
europepmc +1 more source
Strategic Modulation of Isoniazid Solubility through Cocrystal Formation for Long-Acting Microneedle Therapy of Tuberculosis. [PDF]
ACS Appl Mater InterfacesFandiño OE +4 more
europepmc +1 more source
Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer. [PDF]
PharmaceuticsFrösler HM +5 more
europepmc +1 more source
An Optimization Approach for the Production of High-Purity Vitamin C‑Nicotinamide Cocrystals by the Gas Antisolvent (GAS) Technique with CO<sub>2</sub> and Ethanol. [PDF]
ACS OmegaBalbinot Filho CA +8 more
europepmc +1 more source
Sublimation aides and abets co-milling and discoloration involving quinhydrone. [PDF]
Front ChemEzekiel CI, MacGillivray LR.
europepmc +1 more source
Integrative green synthesis and molecular simulation of ibrutinib cocrystals for enhanced biopharmaceutical performance and in vivo pharmacokinetics. [PDF]
Int J Pharm XKara DD +3 more
europepmc +1 more source
A quality by design strategy for cocrystal design based on novel computational and experimental screening strategies: part A. [PDF]
Drug Deliv Transl ResRoss SA +4 more
europepmc +1 more source